Pharmacokinetic Study of Eicosapentaenoic Acid (EPA) and Calcium L-5-Methyltetrahydrofolate (L-5-MTHF) After Administration of CreNeuroS® CNS Fish Oil Plus Softgels in Healthy Subjects Under Fasting Conditions

Inclusion Criteria: * Subjects who have no evidence of underlying disease during screening and check-in and whose screening is performed within 21 days of check in. * Subjects whose screening laboratory values are within normal limits are considered by the physician or principal/clinical investigator to be of no clinical significance. * Healthy as documented by the medical history, physical examination and vital examinations. * Generally healthy, as documented by a 12-lead electrocardiogram (ECG), Chest X-Ray and clinical laboratory assessments. * Willing to consume Ovo lacto-vegetarian diet. * Willing to comply with all requirements of this study protocol as well as instructions from the study personnel. * Generally healthy, as documented by gynaecological examination and breast examination (for female subjects). Exclusion Criteria: * Evidence of allergy or known hypersensitivity to Eicosapentaenoic Acid (EPA) and Calcium L-S-Methyltetrahydrofolate (L-S-MTHF) or its inactive ingredients. * Evidence of allergy to fish or shellfish. * Subjects with hepatic encephalopathy, cholestasis, myasthenia, pre-existing liver disease, alcohol abuse, existing tinnitus, and pre-existing gall bladder disease. * Any major illness in the last three months or any significant ongoing chronic medical illness. * Renal or liver impairment.